NGM Biopharmaceuticals (NGM) News Today → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free NGM Stock Alerts $1.54 -0.02 (-1.28%) (As of 04/5/2024) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineNGM Biopharmaceuticals (NASDAQ:NGM) Trading Down 1.3%americanbankingnews.com - April 16 at 1:52 AMNGM Biopharmaceuticals, Inc.: NGM Bio Announces Closing of Tender Offerfinanznachrichten.de - April 5 at 1:12 PMNGM Bio Announces Closing of Tender Offerglobenewswire.com - April 5 at 9:19 AMmarketbeat.com - April 5 at 6:02 AMNGM Bio to Present Two Posters Highlighting Clinical Data from the Ongoing Phase 1/2 Clinical Trial of NGM707, a Dual ILT2/ILT4 Antagonist Antibody Product Candidate, at AACR 2024 Annual Meetingglobenewswire.com - March 19 at 5:30 PMNGM BIOPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NGM Biopharmaceuticals, Inc. - NGMbusinesswire.com - March 13 at 11:44 AMHow a VC and a biotech founder plan to create a new biotech modelbizjournals.com - March 12 at 7:45 PMOracle, Dollar General upgraded: Wall Street's top analyst callsmsn.com - March 12 at 2:03 PMNGM Biopharmaceuticals (NASDAQ:NGM) Lowered to "Market Perform" at Raymond Jamesmarketbeat.com - March 12 at 8:21 AMNGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Resultsglobenewswire.com - March 11 at 4:05 PMNGM Biopharmaceuticals (NASDAQ:NGM) Downgraded to Neutral at B. Rileymarketbeat.com - February 29 at 7:40 AMTD Cowen Downgrades NGM Biopharmaceuticals (NGM)msn.com - February 29 at 5:26 AMTD Cowen Downgrades NGM Biopharmaceuticals (NASDAQ:NGM) to Market Performmarketbeat.com - February 28 at 7:32 AMNGM BIOPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NGM Biopharmaceuticals, Inc. - NGMbusinesswire.com - February 27 at 4:10 PMNGM Biopharmaceuticals (NASDAQ:NGM) Downgraded by Citigroupmarketbeat.com - February 27 at 9:26 AMThe Column Group moves forward with plan to take NGM Bio privatebizjournals.com - February 26 at 6:25 PMNGM Biopharmaceuticals, Inc.: NGM Bio Has Entered into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group, LPfinanznachrichten.de - February 26 at 1:25 PMNGM Bio To Be Acquired By Affiliates Of The Column Group, LPmarkets.businessinsider.com - February 26 at 1:25 PMNGM to go private through deal with investment firmfinance.yahoo.com - February 26 at 1:25 PMNGM Biopharmaceuticals Shares Drop 20% After $1.55/Shr Buyout Offermarketwatch.com - February 26 at 1:25 PMNGM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NGM Biopharmaceuticals, Inc. Is Fair to Shareholdersbusinesswire.com - February 26 at 11:41 AMNGM Biopharmaceuticals Gets Buyout Offer From Column Group Affliatesmarketwatch.com - February 26 at 10:01 AMNGM Bio to go private in a $135M deal with Atlas Neonmsn.com - February 26 at 10:01 AMNGM Bio Has Entered into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group, LPglobenewswire.com - February 26 at 9:03 AMmarketbeat.com - February 26 at 8:51 AMNGM Biopharmaceuticals (NGM) Scheduled to Post Earnings on Mondaymarketbeat.com - February 25 at 7:32 AMAscites Market to Observe Stunning Growth During the Study Period (2019–2032) | DelveInsightfinance.yahoo.com - February 22 at 12:55 AMNGM Bio to Participate in the Cowen 44th Annual Health Care Conferencefinance.yahoo.com - February 20 at 7:34 PMNGM Bio to Participate in the Cowen 44th Annual Health Care Conferenceglobenewswire.com - February 20 at 4:01 PMNGM Biopharmaceuticals, Inc. (NASDAQ:NGM) Sees Significant Increase in Short Interestmarketbeat.com - February 17 at 6:35 AMNGM Biopharmaceuticals, Inc. (NGM)ca.finance.yahoo.com - February 13 at 8:23 AMLooking Into NGM Biopharmaceuticals's Recent Short Interestbenzinga.com - January 19 at 10:05 AMNGM Bio to Participate in the B. Riley Securities 4th Annual Oncology Conferencefinance.yahoo.com - January 17 at 8:46 PMNGM Biopharmaceuticals, Inc. (NASDAQ:NGM) Short Interest Down 34.4% in Decembermarketbeat.com - January 14 at 7:58 PMNGM Biopharma gains on Phase 1 data update for cancer therapymsn.com - January 9 at 3:51 PMNGM Biopharmaceuticals Stock (NASDAQ:NGM) Dividends: History, Yield and Datesbenzinga.com - January 9 at 8:17 AMNGM Bio Announces New Clinical Data from Ongoing Trial of NGM707 in Advanced Solid Tumors and Outlines Evolved Strategy for Aldafermin and NGM120 to Focus on Rare Conditions with Significant Unmet Needfinance.yahoo.com - January 9 at 8:17 AMBiotech VC wants to take one of its portfolio companies private againbizjournals.com - January 3 at 3:18 PMGreat week for NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) institutional investors after losing 75% over the previous yearfinance.yahoo.com - January 3 at 10:18 AMNGM Biopharma jumps on take-private offermsn.com - January 2 at 5:57 PMWhy NGM Biopharmaceuticals Stock Is Blasting Higherbenzinga.com - January 2 at 1:21 PMNGM Biopharmaceuticals Inc NGMmorningstar.com - November 24 at 9:14 AMB. Riley Securities Maintains Buy Rating for NGM Biopharmaceuticals: Here's What You Need To Knowmarkets.businessinsider.com - November 22 at 2:47 PMHere's Why We're A Bit Worried About NGM Biopharmaceuticals' (NASDAQ:NGM) Cash Burn Situationfinance.yahoo.com - November 22 at 2:47 PMNGM Biopharmaceuticals 10% owner Column Group discloses purchase of over 22K sharesmsn.com - November 20 at 2:15 PMNGM Biopharmaceuticals Inc 0IKmorningstar.com - November 17 at 8:33 PMNGM Bio Presents Positive Phase 2b Results from the ALPINE 4 Trial of Aldafermin in Patients with Compensated Cirrhosis (F4) Due to NASH at AASLD The Liver Meeting®finance.yahoo.com - November 13 at 12:16 PMChief Executive Officer at NGM Biopharmaceuticals Exercises Options Worth $2.24Mbenzinga.com - November 9 at 10:57 PMSVP at NGM Biopharmaceuticals Exercises Options Worth $412Kbenzinga.com - November 9 at 12:56 PMNGM Biopharmaceuticals EVP Acquires 615,000 Shares After Exercising Company Stock Optionsbenzinga.com - November 9 at 12:56 PM Get NGM Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NGM and its competitors with MarketBeat's FREE daily newsletter. Email Address SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. NGM Media Mentions By Week NGM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NGM News Sentiment▼0.000.44▲Average Medical News Sentiment NGM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NGM Articles This Week▼01▲NGM Articles Average Week Get NGM Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NGM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VTGN News Today KNTE News Today SYRS News Today PRQR News Today ASMB News Today THRX News Today VTVT News Today BYSI News Today IMMP News Today AVRO News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NGM) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NGM Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
